Drug Data for Clinical Decision Support

Companies developing new EMRs for small to medium healthcare settings and drug information

Friday, October 21, 2011 by David Wilkof
Drug Nomenclature
Companies developing new EMRs for small to medium healthcare settings often wait too long to consider what drug information provider to use for their product.   There are only a few drug information providers and it is advisable to know the pluses and minuses as early in the process as possible.    It is not just about drug-drug and drug-allergy interactions.  It is not just about drug dosing information,  drug nomenclature,  dosing precautions,  patient education leaflets,  branded and generic medication lists. 

It is also about which vendor is the easiest to work with.  Who will accomodate your needs and not their needs.  Who will help you resolve cerifying body issues?  Who is the best of the best when it comes to pediatric dosing?   Who will provide decision trees for black box warnings?  Who will provide easy to use APIs?   Who provides ongoing topnotch communication?  And who is at the cutting edge?    Those are just some of the quesitons you need to answer.

Comments for Companies developing new EMRs for small to medium healthcare settings and drug information

Leave a comment





Captcha